Eutropics Pharmaceuticals, Inc. — Form D
Eutropics Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-18. The offering totals $2.0M, of which $350K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-11-18
- Form: D
- Accession: 0001892756-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $350K
- Remaining: $1.6M
- Investors: 5
- Date of first sale: 2021-11-03
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-421693
Issuer
- Name: Eutropics Pharmaceuticals, Inc.
- CIK: 0001892756
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 767 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Phone: 617-714-4405
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Michael Cardone | Director | Cambridge, MA |
| Michael Cardone | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More